RedChip Featured Company: RXi Pharmaceuticals Corp. (RXII)
RXi Pharmaceuticals (RXII) is a biopharmaceutical company working towards the development and commercialization of proprietary therapies based upon RNA interference (RNAi). RNAi is considered to be a significant advancement in the field. In 2002, the journal Science selected RNAi as the “Breakthrough of the Year”. The discovery team, which included Dr. Craig Mello, one of the founders of RXi, was awarded the 2006 Nobel Prize in Medicine. It is believed that RNAi, which is a naturally occurring mechanism for the regulation of gene expression, can be used to selectively inhibit the activity of any human gene. RXi hopes to harness…